8-K Announcements
6May 6, 2026·SEC
May 1, 2026·SEC
Apr 16, 2026·SEC
Herbalife Nutrition Ltd. (HLF) fundamental analysis — strengths, weaknesses & financial health based on data analysis
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Herbalife Nutrition Ltd. (HLF) stock price & volume — 10-year historical chart
Herbalife Nutrition Ltd. (HLF) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Herbalife Nutrition Ltd. (HLF) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 18, 2026 | $0.45vs $0.48-6.3% | $1.3Bvs $1.2B+3.1% |
| Q4 2025 | Nov 5, 2025 | $0.50vs $0.47+6.4% | $1.3Bvs $1.2B+2.0% |
| Q3 2025 | Aug 6, 2025 | $0.59vs $0.53+11.3% | $1.3Bvs $1.2B+1.0% |
| Q2 2025 | Apr 30, 2025 | $0.59vs $0.40+47.5% | $1.2Bvs $1.2B-0.3% |
Herbalife Nutrition Ltd. (HLF) competitors in Nutrition and functional foods — business model, growth, and fundamentals comparison
Herbalife Nutrition Ltd. (HLF) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Herbalife Nutrition Ltd. (HLF) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 4.43B | 4.89B | 4.88B | 5.54B | 5.8B | 5.2B | 5.06B | 4.99B | 5.04B | 5.13B |
| Revenue Growth % | -1.35% | 10.48% | -0.3% | 13.63% | 4.71% | -10.31% | -2.73% | -1.37% | 0.89% | 3.69% |
| Cost of Goods Sold | 848.6M | 919.3M | 958M | 1.15B | 1.24B | 1.17B | 1.19B | 1.1B | 1.23B | 1.21B |
| COGS % of Revenue | 19.17% | 18.79% | 19.64% | 20.76% | 21.36% | 22.55% | 23.53% | 22.12% | 24.39% | - |
| Gross Profit | 3.58B▲ 0% | 3.97B▲ 11.0% | 3.92B▼ 1.3% | 4.39B▲ 12.0% | 4.56B▲ 3.9% | 4.03B▼ 11.7% | 3.87B▼ 4.0% | 3.89B▲ 0.4% | 3.81B▼ 2.1% | 3.93B▲ 0% |
| Gross Margin % | 80.83% | 81.21% | 80.36% | 79.24% | 78.64% | 77.45% | 76.47% | 77.88% | 75.61% | 76.51% |
| Gross Profit Growth % | -1.51% | 10.99% | -1.34% | 12.05% | 3.92% | -11.67% | -3.95% | 0.45% | -2.05% | - |
| Operating Expenses | 2.96B | 3.29B | 3.35B | 3.75B | 3.83B | 3.49B | 3.52B | 3.5B | 3.37B | 3.46B |
| OpEx % of Revenue | 66.9% | 67.24% | 68.71% | 67.68% | 65.99% | 66.97% | 69.43% | 70.15% | 66.85% | - |
| Selling, General & Admin | 1.76B | 1.96B | 1.94B | 2.08B | 2.01B | 1.81B | 1.87B | 1.79B | 3.45B | 3.06B |
| SG&A % of Revenue | 39.72% | 39.97% | 39.78% | 37.44% | 34.67% | 34.79% | 36.86% | 35.91% | 68.42% | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 400K | -57.3M | 1.41B | 1.68B | 1.82B | 1.68B | 1.65B | 1.71B | -79.3M | 1000K |
| Operating Income | 617.1M▲ 0% | 683.1M▲ 10.7% | 568.1M▼ 16.8% | 640.6M▲ 12.8% | 734.1M▲ 14.6% | 545.2M▼ 25.7% | 356.4M▼ 34.6% | 385.9M▲ 8.3% | 441.5M▲ 14.4% | 326.3M▲ 0% |
| Operating Margin % | 13.94% | 13.96% | 11.65% | 11.56% | 12.65% | 10.48% | 7.04% | 7.73% | 8.76% | 6.36% |
| Operating Income Growth % | 34.71% | 10.7% | -16.84% | 12.76% | 14.6% | -25.73% | -34.63% | 8.28% | 14.41% | - |
| EBITDA | 716.9M | 783.5M | 665.8M | 740.9M | 841.7M | 660.6M | 469.7M | 507.3M | 562.7M | 416.8M |
| EBITDA Margin % | 16.19% | 16.02% | 13.65% | 13.37% | 14.51% | 12.69% | 9.28% | 10.16% | 11.17% | 8.12% |
| EBITDA Growth % | 28.85% | 9.29% | -15.02% | 11.28% | 13.61% | -21.52% | -28.9% | 8.01% | 10.92% | -25.53% |
| D&A (Non-Cash Add-back) | 99.8M | 100.4M | 97.7M | 100.3M | 107.6M | 115.4M | 113.3M | 121.4M | 121.2M | 90.5M |
| EBIT | 617.1M | 683.1M | 581.1M | 649.4M | 713.9M | 564.1M | 368.9M | 387.7M | 441.5M | 338.6M |
| Net Interest Income | -146.3M | -161.6M | -132.4M | -124.2M | -148.7M | -133.2M | -154.4M | -206M | -205.9M | -153.9M |
| Interest Income | 14.5M | 19.4M | 20.6M | 8.8M | 4.4M | 6.1M | 11.5M | 12.3M | 8.5M | 5.9M |
| Interest Expense | 160.8M | 181M | 153M | 133M | 153.1M | 139.3M | 165.9M | 218.3M | 214.4M | 206.6M |
| Other Income/Expense | -145.9M | -218.9M | -116.7M | -124.2M | -173.3M | -120.4M | -153.4M | -216.5M | -166.4M | -30.4M |
| Pretax Income | 471.2M▲ 0% | 464.2M▼ 1.5% | 451.4M▼ 2.8% | 516.4M▲ 14.4% | 560.8M▲ 8.6% | 424.8M▼ 24.3% | 203M▼ 52.2% | 169.4M▼ 16.6% | 275.1M▲ 62.4% | 295.9M▲ 0% |
| Pretax Margin % | 10.64% | 9.49% | 9.26% | 9.32% | 9.66% | 8.16% | 4.01% | 3.39% | 5.46% | 5.76% |
| Income Tax | 257.3M | 167.6M | 140.4M | 143.8M | 113.6M | 103.5M | 60.8M | -84.9M | 46.8M | 56.1M |
| Effective Tax Rate % | 54.61% | 36.11% | 31.1% | 27.85% | 20.26% | 24.36% | 29.95% | -50.12% | 17.01% | 18.96% |
| Net Income | 213.9M▲ 0% | 296.6M▲ 38.7% | 311M▲ 4.9% | 372.6M▲ 19.8% | 447.2M▲ 20.0% | 321.3M▼ 28.2% | 142.2M▼ 55.7% | 254.3M▲ 78.8% | 228.3M▼ 10.2% | 239.8M▲ 0% |
| Net Margin % | 4.83% | 6.06% | 6.38% | 6.72% | 7.71% | 6.17% | 2.81% | 5.09% | 4.53% | 4.67% |
| Net Income Growth % | -17.73% | 38.66% | 4.86% | 19.81% | 20.02% | -28.15% | -55.74% | 78.83% | -10.22% | -14.48% |
| Net Income (Continuing) | 213.9M | 296.6M | 311M | 372.6M | 447.2M | 321.3M | 142.2M | 254.3M | 228.3M | 239.8M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.7M | 7.3M |
| EPS (Diluted) | 1.29▲ 0% | 1.98▲ 53.5% | 2.20▲ 11.1% | 2.77▲ 25.9% | 4.13▲ 49.1% | 3.23▼ 21.8% | 1.42▼ 56.0% | 2.50▲ 76.1% | 2.20▼ 12.0% | 2.21▲ 0% |
| EPS Growth % | -14.57% | 53.49% | 11.11% | 25.91% | 49.1% | -21.79% | -56.04% | 76.06% | -12% | -16.79% |
| EPS (Basic) | 1.35 | 1.98 | 2.26 | 2.83 | 4.22 | 3.26 | 1.44 | 2.53 | 2.22 | - |
| Diluted Shares Outstanding | 165.7M | 149.5M | 141.6M | 134.5M | 108.3M | 99.5M | 100.2M | 101.6M | 103.6M | 108.4M |
| Basic Shares Outstanding | 158.5M | 149.5M | 137.4M | 131.5M | 105.9M | 98.5M | 99M | 100.6M | 102.8M | 103.8M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
Herbalife Nutrition Ltd. (HLF) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 1.86B | 1.8B | 1.49B | 1.78B | 1.43B | 1.36B | 1.4B | 1.14B | 1.14B | 1.25B |
| Cash & Short-Term Investments | 1.28B | 1.2B | 839.4M | 1.05B | 601.5M | 508M | 575.2M | 415.3M | 353.1M | 451.2M |
| Cash Only | 1.28B | 1.2B | 839.4M | 1.05B | 601.5M | 508M | 575.2M | 415.3M | 353.1M | 451.2M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 93.3M | 70.5M | 79.7M | 83.3M | 66.9M | 70.6M | 81.2M | 68.9M | 91.9M | 106M |
| Days Sales Outstanding | 7.69 | 5.26 | 5.96 | 5.49 | 4.21 | 4.95 | 5.85 | 5.04 | 6.66 | 7.14 |
| Inventory | 341.2M | 381.8M | 436.2M | 501.4M | 575.7M | 580.7M | 505.2M | 475.4M | 511.7M | 494.6M |
| Days Inventory Outstanding | 146.76 | 151.59 | 166.19 | 159.06 | 169.56 | 180.6 | 154.83 | 157.13 | 152.02 | 153.77 |
| Other Current Assets | 147M | 0 | 0 | 0 | 0 | 196.8M | 237.7M | 184.1M | 188M | 200.3M |
| Total Non-Current Assets | 1.03B | 984.8M | 1.19B | 1.3B | 1.39B | 1.38B | 1.41B | 1.58B | 1.64B | 1.62B |
| Property, Plant & Equipment | 377.5M | 360M | 561M | 613M | 662.1M | 693.4M | 692.3M | 645.9M | 616M | 598.3M |
| Fixed Asset Turnover | 11.73x | 13.59x | 8.69x | 9.04x | 8.76x | 7.51x | 7.31x | 7.73x | 8.18x | 8.24x |
| Goodwill | 96.9M | 92.9M | 91.5M | 100.5M | 95.4M | 93.2M | 95.4M | 87.7M | 100.5M | 99.1M |
| Intangible Assets | 310.1M | 310.1M | 310.1M | 313.3M | 317.3M | 315.7M | 314M | 312.3M | 315.1M | 314.6M |
| Long-Term Investments | -77.5M | 12.8M | 0 | 0 | 0 | 0 | 0 | 18.5M | 24.5M | 61.9M |
| Other Non-Current Assets | 250.3M | 129.9M | 227.8M | 273.5M | 313.2M | 142M | 129.1M | 121.4M | 120.8M | 515.3M |
| Total Assets | 2.9B▲ 0% | 2.79B▼ 3.6% | 2.68B▼ 4.0% | 3.08B▲ 14.8% | 2.82B▼ 8.3% | 2.73B▼ 3.1% | 2.81B▲ 2.8% | 2.73B▼ 2.9% | 2.79B▲ 2.1% | 2.88B▲ 0% |
| Asset Turnover | 1.53x | 1.75x | 1.82x | 1.80x | 2.06x | 1.90x | 1.80x | 1.83x | 1.81x | 1.85x |
| Asset Growth % | 12.85% | -3.64% | -3.99% | 14.84% | -8.33% | -3.11% | 2.83% | -2.89% | 2.12% | 16.02% |
| Total Current Liabilities | 906.8M | 1.59B | 964.4M | 1.13B | 1.08B | 976.6M | 1.28B | 1.23B | 1.01B | 1.02B |
| Accounts Payable | 67.8M | 81.1M | 81.6M | 88.7M | 92M | 89.8M | 84M | 70M | 99.8M | 88.1M |
| Days Payables Outstanding | 29.16 | 32.2 | 31.09 | 28.14 | 27.1 | 27.93 | 25.74 | 23.14 | 29.65 | 27.83 |
| Short-Term Debt | 102.4M | 678.9M | 24.1M | 22.7M | 29M | 29.5M | 309.5M | 283.5M | 56.4M | 9.2M |
| Deferred Revenue (Current) | 65.2M | 65.6M | 64.3M | 68.5M | 63M | 53.9M | 64M | 0 | 0 | 81.8M |
| Other Current Liabilities | 619.3M | 690.9M | 415.7M | 522M | 535.1M | 451.6M | 469.7M | 824.6M | 836.1M | 1.01B |
| Current Ratio | 2.05x | 1.14x | 1.54x | 1.58x | 1.33x | 1.39x | 1.10x | 0.93x | 1.13x | 1.13x |
| Quick Ratio | 1.68x | 0.90x | 1.09x | 1.13x | 0.79x | 0.79x | 0.70x | 0.54x | 0.62x | 0.62x |
| Cash Conversion Cycle | 125.29 | 124.65 | 141.07 | 136.41 | 146.67 | 157.63 | 134.94 | 139.03 | 129.03 | 133.07 |
| Total Non-Current Liabilities | 2.32B | 1.92B | 2.1B | 2.8B | 3.13B | 3.02B | 2.59B | 2.3B | 2.28B | 2.29B |
| Long-Term Debt | 2.17B | 1.77B | 1.78B | 2.41B | 2.73B | 2.66B | 2.25B | 1.98B | 2.13B | 155.2M |
| Capital Lease Obligations | 0 | 0 | 169.9M | 207M | 201.9M | 192.4M | 167.6M | 170.7M | 157.3M | 479.7M |
| Deferred Tax Liabilities | 7.8M | 7.5M | 0 | 0 | 0 | 0 | 0 | 0 | 18.9M | 36.7M |
| Other Non-Current Liabilities | 157.3M | 149.5M | 155.4M | 192.7M | 196.5M | 166.4M | 171.6M | 152.7M | -19.6M | 2.4B |
| Total Liabilities | 3.23B | 3.51B | 3.07B | 3.93B | 4.21B | 4B | 3.87B | 3.53B | 3.3B | 3.31B |
| Total Debt | 2.27B | 2.45B | 2.01B | 2.67B | 3.01B | 2.92B | 2.77B | 2.47B | 2.34B | 164.4M |
| Net Debt | 989.3M | 1.25B | 1.17B | 1.63B | 2.41B | 2.41B | 2.19B | 2.05B | 1.99B | -286.8M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | -0.38x |
| Debt / EBITDA | 3.16x | 3.13x | 3.02x | 3.60x | 3.57x | 4.42x | 5.90x | 4.87x | 4.16x | 0.39x |
| Net Debt / EBITDA | 1.38x | 1.60x | 1.76x | 2.19x | 2.86x | 3.65x | 4.67x | 4.05x | 3.53x | 3.53x |
| Interest Coverage | 3.84x | 3.77x | 3.80x | 4.88x | 4.66x | 4.05x | 2.22x | 1.78x | 2.06x | 1.64x |
| Total Equity | -334.7M▲ 0% | -723.4M▼ 116.1% | -390M▲ 46.1% | -856.1M▼ 119.5% | -1.39B▼ 62.5% | -1.27B▲ 9.0% | -1.06B▲ 16.2% | -801.1M▲ 24.4% | -509.4M▲ 36.4% | -434.2M▲ 0% |
| Equity Growth % | -270.5% | -116.13% | 46.09% | -119.51% | -62.54% | 9.03% | 16.24% | 24.45% | 36.41% | 150.82% |
| Book Value per Share | -2.02 | -4.84 | -2.75 | -6.37 | -12.85 | -12.72 | -10.58 | -7.88 | -4.92 | -4.01 |
| Total Shareholders' Equity | -334.7M | -723.4M | -390M | -856.1M | -1.39B | -1.27B | -1.06B | -801.1M | -515.1M | -441.5M |
| Common Stock | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K |
| Retained Earnings | -248.1M | -526.3M | -215.3M | -687.4M | -1.17B | -1.2B | -1.06B | -808M | -579.7M | -517.8M |
| Treasury Stock | -328.6M | -328.9M | -328.9M | -328.9M | -328.9M | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -165.4M | -209.8M | -212.5M | -182.2M | -211.8M | -250.2M | -232M | -271.4M | -251.5M | -257.8M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.7M | 7.3M |
Herbalife Nutrition Ltd. (HLF) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 590.8M | 648.4M | 457.5M | 628.6M | 460.3M | 352.5M | 357.5M | 285.4M | 333.3M | 333.3M |
| Operating CF Margin % | 13.34% | 13.25% | 9.38% | 11.34% | 7.93% | 6.77% | 7.06% | 5.72% | 6.62% | - |
| Operating CF Growth % | 60.85% | 9.75% | -29.44% | 37.4% | -26.77% | -23.42% | 1.42% | -20.17% | 16.78% | 56874.39% |
| Net Income | 213.9M | 296.6M | 311M | 372.6M | 447.2M | 321.3M | 142.2M | 254.3M | 227.8M | 239.8M |
| Depreciation & Amortization | 99.8M | 100.4M | 97.7M | 100.3M | 107.6M | 115.4M | 113.3M | 121.4M | 121.2M | 119.9M |
| Stock-Based Compensation | 42.1M | 35.5M | 38.6M | 51M | 54.1M | 44.4M | 48M | 50M | 44.1M | 43.1M |
| Deferred Taxes | 97.8M | -8.1M | 15.4M | 2M | -33.3M | -29.9M | -41.1M | -229.6M | -64.2M | -50.8M |
| Other Non-Cash Items | 85.2M | 144.8M | 57M | 62.5M | 103M | 24.4M | 47.4M | 56.8M | 39.9M | 36M |
| Working Capital Changes | 52M | 79.2M | -62.2M | 40.2M | -218.3M | -123.1M | 47.7M | 32.5M | -35.5M | 59.4M |
| Change in Receivables | -22.2M | 127.3M | 19.9M | 121.1M | 9.6M | -9.1M | -9.1M | 5.9M | -19.7M | -14M |
| Change in Inventory | 37.9M | -83.3M | -68.6M | -76.6M | -129.1M | -68.4M | 57.5M | -30.4M | -27.9M | -5.3M |
| Change in Payables | -5M | 21.7M | 100K | 5.5M | 6.9M | -1.1M | -7.4M | -14.6M | 24.1M | 500K |
| Cash from Investing | -97.8M | -83.9M | -108M | -123.2M | -156.4M | -156.2M | -134.8M | -84.6M | -108.7M | -101.1M |
| Capital Expenditures | -95.5M | -84M | -106.1M | -112M | -151.4M | -156.4M | -135M | -122M | -80.4M | -73M |
| CapEx % of Revenue | 2.16% | 1.72% | 2.18% | 2.02% | 2.61% | 3.01% | 2.67% | 2.44% | 1.6% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -2.3M | 100K | -1.9M | -11.2M | -5M | 200K | 200K | 37.4M | -28.3M | -28.1M |
| Cash from Financing | -85.2M | -593.1M | -713M | -320.9M | -728.6M | -264.7M | -148.3M | -335.3M | -295.5M | -221.3M |
| Debt Issued (Net) | 779.5M | 128.2M | -699.5M | 607M | 286.9M | -115M | -138.7M | -305.5M | -284.2M | 5.3M |
| Equity Issued (Net) | -844.2M | -750.3M | -16.7M | -923.5M | -1.01B | -146.7M | -11M | -8.3M | -8.2M | 2.2M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -844.2M | -750.3M | -16.7M | -923.5M | -1.01B | -146.7M | -11M | -8.3M | -8.2M | 2.2M |
| Other Financing | -20.5M | 29M | 3.2M | -4.4M | -4.2M | -3M | 1.4M | -21.5M | -3.1M | -228.8M |
| Net Change in Cash | 434.8M▲ 0% | -80.5M▼ 118.5% | -367.5M▼ 356.5% | 206.5M▲ 156.2% | -443.6M▼ 314.8% | -94.1M▲ 78.8% | 79.2M▲ 184.2% | -157.4M▼ 298.7% | -62.8M▲ 60.1% | 122M▲ 0% |
| Free Cash Flow | 495.3M▲ 0% | 564.4M▲ 14.0% | 351.4M▼ 37.7% | 516.6M▲ 47.0% | 308.9M▼ 40.2% | 196.1M▼ 36.5% | 222.5M▲ 13.5% | 163.4M▼ 26.6% | 252.9M▲ 54.8% | 373.9M▲ 0% |
| FCF Margin % | 11.19% | 11.54% | 7.21% | 9.32% | 5.32% | 3.77% | 4.4% | 3.27% | 5.02% | 7.28% |
| FCF Growth % | 121.21% | 13.95% | -37.74% | 47.01% | -40.21% | -36.52% | 13.46% | -26.56% | 54.77% | 127.43% |
| FCF per Share | 2.99 | 3.78 | 2.48 | 3.84 | 2.85 | 1.97 | 2.22 | 1.61 | 2.44 | 2.44 |
| FCF Conversion (FCF/Net Income) | 2.76x | 2.19x | 1.47x | 1.69x | 1.03x | 1.10x | 2.51x | 1.12x | 1.46x | 1.56x |
| Interest Paid | 100.7M | 106.1M | 114.3M | 78.9M | 143.5M | 133.5M | 159.1M | 194.4M | 0 | 0 |
| Taxes Paid | 158.8M | 158.9M | 147.9M | 138.2M | 156.3M | 144.9M | 133.1M | 146.5M | 0 | 0 |
Herbalife Nutrition Ltd. (HLF) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | - | - | - | - | - | - | - | -43.52% |
| Return on Invested Capital (ROIC) | 63.63% | 86.39% | 64.93% | 61.99% | 61.77% | 37.83% | 23.43% | 24.25% | 24.26% | 24.26% |
| Gross Margin | 80.83% | 81.21% | 80.36% | 79.24% | 78.64% | 77.45% | 76.47% | 77.88% | 75.61% | 76.51% |
| Net Margin | 4.83% | 6.06% | 6.38% | 6.72% | 7.71% | 6.17% | 2.81% | 5.09% | 4.53% | 4.67% |
| Debt / Equity | - | - | - | - | - | - | - | - | - | -0.38x |
| Interest Coverage | 3.84x | 3.77x | 3.80x | 4.88x | 4.66x | 4.05x | 2.22x | 1.78x | 2.06x | 1.64x |
| FCF Conversion | 2.76x | 2.19x | 1.47x | 1.69x | 1.03x | 1.10x | 2.51x | 1.12x | 1.46x | 1.56x |
| Revenue Growth | -1.35% | 10.48% | -0.3% | 13.63% | 4.71% | -10.31% | -2.73% | -1.37% | 0.89% | 3.69% |
Herbalife Nutrition Ltd. (HLF) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 6, 2026·SEC
May 1, 2026·SEC
Apr 16, 2026·SEC
Herbalife Nutrition Ltd. (HLF) stock FAQ — growth, dividends, profitability & financials explained
Herbalife Nutrition Ltd. (HLF) reported $5.13B in revenue for fiscal year 2025. This represents a 343% increase from $1.16B in 2003.
Herbalife Nutrition Ltd. (HLF) grew revenue by 0.9% over the past year. Growth has been modest.
Yes, Herbalife Nutrition Ltd. (HLF) is profitable, generating $239.8M in net income for fiscal year 2025 (4.5% net margin).
Herbalife Nutrition Ltd. (HLF) generated $373.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Herbalife Nutrition Ltd. (HLF) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates